Literature DB >> 1731438

Blood loss and replacement in total hip arthroplasty: a multicenter study. The Preoperative Autologous Blood Donation Study Group.

P T Toy1, E B Kaplan, P A McVay, S J Lee, R G Strauss, L C Stehling.   

Abstract

To determine blood loss, the number of transfusions, and the hemoglobin levels achieved in patients via transfusion in the course of total hip arthroplasty, 324 patient records from 1987 through 1989 were reviewed at three university and three community hospitals. Calculated blood loss was 3.2 +/- 1.3 units in primary procedures and 4.0 +/- 2.1 units in revision procedures (mean +/- SD). Of 777 red cell units transfused, 455 (59%) were autologous units. Transfused patients received 2.0 +/- 1.8 units for primary procedures and 2.9 +/- 2.3 units for revision procedures (mean +/- SD). The maximum number of units given to 95 percent of the transfused patients was 4 for primary procedures and 6 for revision procedures. The mean postoperative hemoglobin level after all transfusions was 103 to 110 g per L, regardless of patient age group of physical status, autologous donor status, or hospital. No difference in length of hospital stay was observed for patients less than 65 years old with hemoglobin concentrations of 80 to 139 g per L at discharge.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1731438     DOI: 10.1046/j.1537-2995.1992.32192116435.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  14 in total

Review 1.  Blood management and patient specific transfusion options in total joint replacement surgery.

Authors:  J J Callaghan; A I Spitzer
Journal:  Iowa Orthop J       Date:  2000

Review 2.  Blood conservation strategies in orthopedic surgeries: A review.

Authors:  Balaji Sambandam; Sahil Batra; Rajat Gupta; Nidhi Agrawal
Journal:  J Clin Orthop Trauma       Date:  2013-12-08

3.  Efficacy of oral tranexamic acid on blood loss in primary total hip arthroplasty using a direct anterior approach: a prospective randomized controlled trial.

Authors:  HaiYan Zhao; MaoYing Xiang; YaYi Xia; Xiaojun Shi; Fu-Xing Pei; PengDe Kang
Journal:  Int Orthop       Date:  2018-02-28       Impact factor: 3.075

4.  Hip arthroplasty, changing trends in a national tertiary referral centre.

Authors:  E Sheehan; M Neligan; P Murray
Journal:  Ir J Med Sci       Date:  2002 Jan-Mar       Impact factor: 1.568

5.  Total hip arthroplasty in patients with haemophilia - What are the risks of bleeding in the immediate peri-operative period?

Authors:  Grainne Colgan; Joseph F Baker; N Donlon; N Hogan; T McCarthy
Journal:  J Orthop       Date:  2016-07-27

6.  Determinants of allogeneic transfusion among patients who had an autologous blood procedure, France.

Authors:  Simone Mathoulin-Pélissier; Louis Rachid Salmi; Charlotte Huët
Journal:  Eur J Epidemiol       Date:  2004       Impact factor: 8.082

7.  The clinical efficacy of using autologous platelet rich plasma in hip arthroplasty: A retrospective comparative study.

Authors:  Atif Safdar; Hamid Shaaban; Restituto Tibayan; Richard Miller; Richard Boairdo; Gunwant Guron
Journal:  J Nat Sci Biol Med       Date:  2015 Jan-Jun

8.  Topical Versus Intravenous Administration of Tranexamic Acid in Primary Total Hip Arthroplasty: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Authors:  Sammy A Hanna; Anoop Prasad; Joshua Lee; Pramod Achan
Journal:  Orthop Rev (Pavia)       Date:  2016-09-19

Review 9.  Tranexamic acid for the prevention and management of orthopedic surgical hemorrhage: current evidence.

Authors:  Christopher Kim; Sam Si-Hyeong Park; J Roderick Davey
Journal:  J Blood Med       Date:  2015-08-25

10.  Bipolar sealer not superior to standard electrocautery in primary total hip arthroplasty: a meta-analysis.

Authors:  Yang Yang; Li-Chao Zhang; Fei Xu; Jia Li; Yong-Ming Lv
Journal:  J Orthop Surg Res       Date:  2014-10-10       Impact factor: 2.359

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.